Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| fruit/legume fibre - Lacticaseibacillus |
👶
Effect of dark sweet cherry powder consumption on the gut microbiota, short-chain fatty acids, and biomarkers of gut health in obese db/db mice. PeerJ (PeerJ ) Vol: 6 Issue Pages: e4195 Pub: 2018 Epub: 2018 Jan 3 Authors Garcia-Mazcorro JF , Lage NN , Mertens-Talcott S , Talcott S , Chew B , Dowd SE , Kawas JR , Noratto GD , Html Article Publication |
| fruit/legume fibre - Lacticaseibacillus |
👶
Dietary grape seed extract ameliorates symptoms of inflammatory bowel disease in IL10-deficient mice. Molecular nutrition & food research (Mol Nutr Food Res ) Vol: 57 Issue 12 Pages: 2253-7 Pub: 2013 Dec Epub: 2013 Aug 21 Authors Wang H , Xue Y , Zhang H , Huang Y , Yang G , Du M , Zhu MJ , Html Article Publication |
| fruit/legume fibre - Lacticaseibacillus |
👶
Pomegranate peel extract ameliorates the severity of experimental autoimmune encephalomyelitis via modulation of gut microbiota. Gut microbes (Gut Microbes ) Vol: 12 Issue 1 Pages: 1857515 Pub: 2020 Nov 9 Epub: Authors Lu XY , Han B , Deng X , Deng SY , Zhang YY , Shen PX , Hui T , Chen RH , Li X , Zhang Y , Html Article Publication |
| fruit/legume fibre - Lacticaseibacillus |
👪
Solid-State Fermented Pineapple Peel: A Novel Food Ingredient with Antioxidant and Anti-Inflammatory Properties. Foods (Basel, Switzerland) (Foods ) Vol: 12 Issue 22 Pages: Pub: 2023 Nov 17 Epub: 2023 Nov 17 Authors Ortega-Hernández E , Martinez-Alvarado L , Acosta-Estrada BA , Antunes-Ricardo M , Html Article Publication |
| fruit/legume fibre - Lacticaseibacillus |
👪
Lactic acid fermentation of goji berries (Lycium barbarum) prevents acute alcohol liver injury and modulates gut microbiota and metabolites in mice. Food & function (Food Funct ) Vol: 15 Issue 3 Pages: 1612-1626 Pub: 2024 Feb 5 Epub: 2024 Feb 5 Authors Duan W , Zhou L , Ren Y , Liu F , Xue Y , Wang FZ , Lu R , Zhang XJ , Shi JS , Xu ZH , Geng Y , Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
